Follow
John Bartlett
John Bartlett
Director of Transformative Pathology, Ontario Institute for Cancer Research
Verified email at oicr.on.ca - Homepage
Title
Cited by
Cited by
Year
Human epidermal growth factor receptor 2 testing in breast cancer
AC Wolff, MR Somerfield, M Dowsett, MEH Hammond, DF Hayes, ...
Archives of pathology & laboratory medicine 147 (9), 993-1000, 2023
61572023
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice …
AC Wolff, MEH Hammond, DG Hicks, M Dowsett, LM McShane, ...
Journal of clinical oncology 31 (31), 3997-4013, 2013
56242013
Comprehensive molecular characterization of gastric adenocarcinoma
Cancer Genome Atlas Research Network
Nature 513 (7517), 202, 2014
54472014
Integrated genomic characterization of endometrial carcinoma
DA Levine, ...
Nature 497 (7447), 67-73, 2013
51842013
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
48582018
Comprehensive genomic characterization of squamous cell lung cancers
Cancer Genome Atlas Research Network
Nature 489 (7417), 519, 2012
37882012
Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline focused update
AC Wolff, MEH Hammond, KH Allison, BE Harvey, PB Mangu, ...
Archives of pathology & laboratory medicine 142 (11), 1364-1382, 2018
28722018
Genomic classification of cutaneous melanoma
R Akbani, KC Akdemir, B áArman Aksoy, M Albert, A Ally, SB Amin, ...
Cell 161 (7), 1681-1696, 2015
28342015
Comprehensive molecular characterization of urothelial bladder carcinoma
Cancer Genome Atlas Research Network
Nature 507 (7492), 315, 2014
27352014
Comprehensive molecular characterization of muscle-invasive bladder cancer
AG Robertson, J Kim, H Al-Ahmadie, J Bellmunt, G Guo, AD Cherniack, ...
Cell 171 (3), 540-556. e25, 2017
24232017
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
23472018
Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer working group
M Dowsett, TO Nielsen, R A’Hern, J Bartlett, RC Coombes, J Cuzick, ...
Journal of the National cancer Institute 103 (22), 1656-1664, 2011
21092011
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
1934*2020
Integrated genomic characterization of pancreatic ductal adenocarcinoma
BJ Raphael, RH Hruban, AJ Aguirre, RA Moffitt, JJ Yeh, C Stewart, ...
Cancer cell 32 (2), 185-203. e13, 2017
17082017
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials
B Asselain, W Barlow, J Bartlett, J Bergh, E Bergsten-Nordström, J Bliss, ...
The Lancet Oncology 19 (1), 27-39, 2018
10042018
A short history of the polymerase chain reaction
JMS Bartlett, D Stirling
PCR protocols, 3-6, 2003
10042003
Association between CD8+ T-cell infiltration and breast cancer survival in 12 439 patients
HR Ali, E Provenzano, SJ Dawson, FM Blows, B Liu, M Shah, HM Earl, ...
Annals of Oncology 25 (8), 1536-1543, 2014
8582014
Expression of the HER1–4 family of receptor tyrosine kinases in breast cancer
CJ Witton, JR Reeves, JJ Going, TG Cooke, JMS Bartlett
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2003
7542003
An international Ki67 reproducibility study
MYC Polley, SCY Leung, LM McShane, D Gao, JC Hugh, ...
Journal of the National Cancer Institute 105 (24), 1897-1906, 2013
6932013
Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations
G Sauter, J Lee, JMS Bartlett, DJ Slamon, MF Press
Journal of Clinical Oncology 27 (8), 1323-1333, 2009
6642009
The system can't perform the operation now. Try again later.
Articles 1–20